Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck

Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from chec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology 2017-04, Vol.67, p.61-69
Hauptverfasser: Hanna, Glenn J, Liu, Hongye, Jones, Robert E, Bacay, Alyssa F, Lizotte, Patrick H, Ivanova, Elena V, Bittinger, Mark A, Cavanaugh, Megan E, Rode, Amanda J, Schoenfeld, Jonathan D, Chau, Nicole G, Haddad, Robert I, Lorch, Jochen H, Wong, Kwok-Kin, Uppaluri, Ravindra, Hammerman, Peter S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 69
container_issue
container_start_page 61
container_title Oral oncology
container_volume 67
creator Hanna, Glenn J
Liu, Hongye
Jones, Robert E
Bacay, Alyssa F
Lizotte, Patrick H
Ivanova, Elena V
Bittinger, Mark A
Cavanaugh, Megan E
Rode, Amanda J
Schoenfeld, Jonathan D
Chau, Nicole G
Haddad, Robert I
Lorch, Jochen H
Wong, Kwok-Kin
Uppaluri, Ravindra
Hammerman, Peter S
description Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from checkpoint blockade.
doi_str_mv 10.1016/j.oraloncology.2017.02.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1882082470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1368837517300258</els_id><sourcerecordid>1882082470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-59b4c046440c4cc084c975f9c6661b3b0e600a933a063c441bb9ae3388af71973</originalsourceid><addsrcrecordid>eNqNkU9v1DAQxSMEoqXwFZDFiQNZxrGTOByQqpZ_UiUOwNlyJpOut4md2g7SfnscbUGIEyeP5PfezPymKF5x2HHgzdvDzgczeYd-8rfHXQW83UG1A6gfFedctV0JdSce51o0qlSirc-KZzEeICt4DU-Ls0qJXKnqvFiuabTOultmHLNunMxMA0vr7AOz87w6v-zJ-XRcKH-zQLiGQC69YTMlE5NJFlm8X83s18iQpomhCWidnw3zI0t7YnsyQ44fmCO8e148Gc0U6cXDe1H8-Pjh-9Xn8ubrpy9XlzclSlGnsu56iSAbKQElIiiJXVuPHTZNw3vRAzUAphPCQCNQSt73nSEhlDJjy7tWXBSvT7lL8PcrxaRnG7f5jKM8quZKVaAq2UKWvjtJMfgYA416CXY24ag56I24Pui_ieuNuIZKZ57Z_PKhz9pndH-svxFnwfVJQHnbn5aCjmjJIQ0200x68Pb_-rz_JwanfDg00x0dKR78GlzmqbmO2aC_bbffTs9bAVDVSvwCKyuvNw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1882082470</pqid></control><display><type>article</type><title>Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hanna, Glenn J ; Liu, Hongye ; Jones, Robert E ; Bacay, Alyssa F ; Lizotte, Patrick H ; Ivanova, Elena V ; Bittinger, Mark A ; Cavanaugh, Megan E ; Rode, Amanda J ; Schoenfeld, Jonathan D ; Chau, Nicole G ; Haddad, Robert I ; Lorch, Jochen H ; Wong, Kwok-Kin ; Uppaluri, Ravindra ; Hammerman, Peter S</creator><creatorcontrib>Hanna, Glenn J ; Liu, Hongye ; Jones, Robert E ; Bacay, Alyssa F ; Lizotte, Patrick H ; Ivanova, Elena V ; Bittinger, Mark A ; Cavanaugh, Megan E ; Rode, Amanda J ; Schoenfeld, Jonathan D ; Chau, Nicole G ; Haddad, Robert I ; Lorch, Jochen H ; Wong, Kwok-Kin ; Uppaluri, Ravindra ; Hammerman, Peter S</creatorcontrib><description>Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from checkpoint blockade.</description><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2017.02.005</identifier><identifier>PMID: 28351582</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biomarkers ; Carcinoma, Squamous Cell - immunology ; Carcinoma, Squamous Cell - pathology ; Female ; Head and neck cancer ; Head and Neck Neoplasms - immunology ; Head and Neck Neoplasms - pathology ; Hematology, Oncology and Palliative Medicine ; Humans ; Immunophenotyping ; Immunotherapy ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Otolaryngology ; PD-1 ; Squamous Cell Carcinoma of Head and Neck ; Survival</subject><ispartof>Oral oncology, 2017-04, Vol.67, p.61-69</ispartof><rights>Elsevier Ltd</rights><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-59b4c046440c4cc084c975f9c6661b3b0e600a933a063c441bb9ae3388af71973</citedby><cites>FETCH-LOGICAL-c435t-59b4c046440c4cc084c975f9c6661b3b0e600a933a063c441bb9ae3388af71973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.oraloncology.2017.02.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28351582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hanna, Glenn J</creatorcontrib><creatorcontrib>Liu, Hongye</creatorcontrib><creatorcontrib>Jones, Robert E</creatorcontrib><creatorcontrib>Bacay, Alyssa F</creatorcontrib><creatorcontrib>Lizotte, Patrick H</creatorcontrib><creatorcontrib>Ivanova, Elena V</creatorcontrib><creatorcontrib>Bittinger, Mark A</creatorcontrib><creatorcontrib>Cavanaugh, Megan E</creatorcontrib><creatorcontrib>Rode, Amanda J</creatorcontrib><creatorcontrib>Schoenfeld, Jonathan D</creatorcontrib><creatorcontrib>Chau, Nicole G</creatorcontrib><creatorcontrib>Haddad, Robert I</creatorcontrib><creatorcontrib>Lorch, Jochen H</creatorcontrib><creatorcontrib>Wong, Kwok-Kin</creatorcontrib><creatorcontrib>Uppaluri, Ravindra</creatorcontrib><creatorcontrib>Hammerman, Peter S</creatorcontrib><title>Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><description>Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from checkpoint blockade.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers</subject><subject>Carcinoma, Squamous Cell - immunology</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Female</subject><subject>Head and neck cancer</subject><subject>Head and Neck Neoplasms - immunology</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Immunotherapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Recurrence, Local</subject><subject>Otolaryngology</subject><subject>PD-1</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><subject>Survival</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9v1DAQxSMEoqXwFZDFiQNZxrGTOByQqpZ_UiUOwNlyJpOut4md2g7SfnscbUGIEyeP5PfezPymKF5x2HHgzdvDzgczeYd-8rfHXQW83UG1A6gfFedctV0JdSce51o0qlSirc-KZzEeICt4DU-Ls0qJXKnqvFiuabTOultmHLNunMxMA0vr7AOz87w6v-zJ-XRcKH-zQLiGQC69YTMlE5NJFlm8X83s18iQpomhCWidnw3zI0t7YnsyQ44fmCO8e148Gc0U6cXDe1H8-Pjh-9Xn8ubrpy9XlzclSlGnsu56iSAbKQElIiiJXVuPHTZNw3vRAzUAphPCQCNQSt73nSEhlDJjy7tWXBSvT7lL8PcrxaRnG7f5jKM8quZKVaAq2UKWvjtJMfgYA416CXY24ag56I24Pui_ieuNuIZKZ57Z_PKhz9pndH-svxFnwfVJQHnbn5aCjmjJIQ0200x68Pb_-rz_JwanfDg00x0dKR78GlzmqbmO2aC_bbffTs9bAVDVSvwCKyuvNw</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Hanna, Glenn J</creator><creator>Liu, Hongye</creator><creator>Jones, Robert E</creator><creator>Bacay, Alyssa F</creator><creator>Lizotte, Patrick H</creator><creator>Ivanova, Elena V</creator><creator>Bittinger, Mark A</creator><creator>Cavanaugh, Megan E</creator><creator>Rode, Amanda J</creator><creator>Schoenfeld, Jonathan D</creator><creator>Chau, Nicole G</creator><creator>Haddad, Robert I</creator><creator>Lorch, Jochen H</creator><creator>Wong, Kwok-Kin</creator><creator>Uppaluri, Ravindra</creator><creator>Hammerman, Peter S</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170401</creationdate><title>Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck</title><author>Hanna, Glenn J ; Liu, Hongye ; Jones, Robert E ; Bacay, Alyssa F ; Lizotte, Patrick H ; Ivanova, Elena V ; Bittinger, Mark A ; Cavanaugh, Megan E ; Rode, Amanda J ; Schoenfeld, Jonathan D ; Chau, Nicole G ; Haddad, Robert I ; Lorch, Jochen H ; Wong, Kwok-Kin ; Uppaluri, Ravindra ; Hammerman, Peter S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-59b4c046440c4cc084c975f9c6661b3b0e600a933a063c441bb9ae3388af71973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers</topic><topic>Carcinoma, Squamous Cell - immunology</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Female</topic><topic>Head and neck cancer</topic><topic>Head and Neck Neoplasms - immunology</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Immunotherapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Recurrence, Local</topic><topic>Otolaryngology</topic><topic>PD-1</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hanna, Glenn J</creatorcontrib><creatorcontrib>Liu, Hongye</creatorcontrib><creatorcontrib>Jones, Robert E</creatorcontrib><creatorcontrib>Bacay, Alyssa F</creatorcontrib><creatorcontrib>Lizotte, Patrick H</creatorcontrib><creatorcontrib>Ivanova, Elena V</creatorcontrib><creatorcontrib>Bittinger, Mark A</creatorcontrib><creatorcontrib>Cavanaugh, Megan E</creatorcontrib><creatorcontrib>Rode, Amanda J</creatorcontrib><creatorcontrib>Schoenfeld, Jonathan D</creatorcontrib><creatorcontrib>Chau, Nicole G</creatorcontrib><creatorcontrib>Haddad, Robert I</creatorcontrib><creatorcontrib>Lorch, Jochen H</creatorcontrib><creatorcontrib>Wong, Kwok-Kin</creatorcontrib><creatorcontrib>Uppaluri, Ravindra</creatorcontrib><creatorcontrib>Hammerman, Peter S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hanna, Glenn J</au><au>Liu, Hongye</au><au>Jones, Robert E</au><au>Bacay, Alyssa F</au><au>Lizotte, Patrick H</au><au>Ivanova, Elena V</au><au>Bittinger, Mark A</au><au>Cavanaugh, Megan E</au><au>Rode, Amanda J</au><au>Schoenfeld, Jonathan D</au><au>Chau, Nicole G</au><au>Haddad, Robert I</au><au>Lorch, Jochen H</au><au>Wong, Kwok-Kin</au><au>Uppaluri, Ravindra</au><au>Hammerman, Peter S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>67</volume><spage>61</spage><epage>69</epage><pages>61-69</pages><issn>1368-8375</issn><eissn>1879-0593</eissn><abstract>Highlights • We identified a group of R/M SCCHN tumors with an inflamed immunophenotype. • We identified a non-inflamed tumor immunophenotype in the same population. • Patients with the inflamed tumor phenotype had improved survival. • Patients with the inflamed tumor phenotype may benefit from checkpoint blockade.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28351582</pmid><doi>10.1016/j.oraloncology.2017.02.005</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1368-8375
ispartof Oral oncology, 2017-04, Vol.67, p.61-69
issn 1368-8375
1879-0593
language eng
recordid cdi_proquest_miscellaneous_1882082470
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Aged
Aged, 80 and over
Biomarkers
Carcinoma, Squamous Cell - immunology
Carcinoma, Squamous Cell - pathology
Female
Head and neck cancer
Head and Neck Neoplasms - immunology
Head and Neck Neoplasms - pathology
Hematology, Oncology and Palliative Medicine
Humans
Immunophenotyping
Immunotherapy
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Otolaryngology
PD-1
Squamous Cell Carcinoma of Head and Neck
Survival
title Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A07%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20an%20inflamed%20tumor%20immunophenotype%20in%20recurrent,%20metastatic%20squamous%20cell%20carcinoma%20of%20the%20head%20and%20neck&rft.jtitle=Oral%20oncology&rft.au=Hanna,%20Glenn%20J&rft.date=2017-04-01&rft.volume=67&rft.spage=61&rft.epage=69&rft.pages=61-69&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2017.02.005&rft_dat=%3Cproquest_cross%3E1882082470%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1882082470&rft_id=info:pmid/28351582&rft_els_id=S1368837517300258&rfr_iscdi=true